Marie-Louise Zeissler

Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis

C. Carroll, J. Zajicek, C. Hanemann, 2016, Oncotarget.

Is It Possible to Conduct a Multi-Arm Multi-Stage Platform Trial in Parkinson’s Disease: Lessons Learned from Other Neurodegenerative Disorders and Cancer

M. Parmar, C. Carroll, V. Li, 2020, Journal of Parkinson's disease.

Outcome Measures for Disease-Modifying Trials in Parkinson’s Disease: Consensus Paper by the EJS ACT-PD Multi-Arm Multi-Stage Trial Initiative

M. Burnell, P. Piccini, A. Jha, 2023, Journal of Parkinson's disease.

Towards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson’s disease

R. Barker, J. Carpenter, T. Foltynie, 2023, Brain : a journal of neurology.

Incorporating usability evaluation into iterative development of an online platform to support research participation in Parkinson’s disease: a mixed methods protocol

E. Meinert, Marie-Louise Zeissler, Sue Whipps, 2023, BMJ Open.

Embedding Patient Input in Outcome Measures for Long‐Term Disease‐Modifying Parkinson Disease Trials

R. Weil, T. Foltynie, C. Williams-Gray, 2023, Movement disorders : official journal of the Movement Disorder Society.

An International Multi-Stakeholder Delphi Survey Study on the Design of Disease Modifying Parkinson’s Disease Trials

Marie-Louise Zeissler, K. McFarthing, Gary Rafaloff, 2023, Journal of Parkinson's disease.